JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on October 8, 2003; DOI: 10.1124/jpet.103.055970


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.103.055970v1
307/3/1007    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jordan, J. E.
Right arrow Articles by Miller, A. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jordan, J. E.
Right arrow Articles by Miller, A. W.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Cardiomyopathy
Hazardous Substances DB
*FRUCTOSE


Received for publication June 20, 2003.
Revised July 7, 2003.
Accepted for publication August 14, 2003.

Fructose-fed rats are protected against ischemia/reperfusion injury

James E. Jordan 1, Steven A. Simandle 2, Christina D. Tulbert 3, David W. Busija 1, Allison W. Miller 1*

1 Wake Forest University School of Medicine 2 Wake Forest University Health Sciences 3 Wake Forest School of Medicine

* Address correspondence to: E-mail: amiller{at}wfubmc.edu

Abstract

This study examines the relationship between insulin resistance (IR) induced by fructose feeding (FF) and susceptibility to myocardial ischemia/reperfusion injury (MI/R). Six week old male, Sprague-Dawley rats were randomized into control (CON, n=59) or FF (n=58) groups. After 4 weeks, rats were further randomized into one of the following groups: placebo, ischemic preconditioning (IPC), 5-hydroxydecanoic acid (5-HD) (10mg/kg), or 5-HD + IPC. Moreover, to determine the role of fructose, a second model of IR (Zucker obese) and rats fed fructose diet for 3 days (FF-3) were also subjected to MI/R. In all experiments, rats were subjected to 30 minutes of myocardial ischemia and 4 hours of reperfusion. In rats randomized to placebo, infarct size was significantly reduced by FF (24±5%) as compared to CON (54 ±1%, p<0.05). 5-HD pretreatment did not alter the infarct size in CON (45±5%), but inhibited the protection afforded by FF (53±7%). IPC reduced the infarct size to an equivalent level in both groups, while 5-HD administration prior to IPC blunted the IPC effect. In Zucker obese rats infarct size was significantly larger (57±4%) compared to lean controls (37±4%, p<0.05). In FF-3 rats, infarct size was also decreased (20±2%, p<0.01) as compared to CON. This study suggests that fructose- feeding affords protection against MI/R that is related to or mimics preconditioning. This protection is not consistent with other models of IR and is likely related to the fructose diet itself.


Key words: Zucker obese rat, fructose-fed rat, insulin resistance, ischemia/reperfusion, mitochondrial KATP channel, preconditioning


This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
T.-L. Yue, S. S. Nerurkar, W. Bao, B. M. Jucker, L. Sarov-Blat, K. Steplewski, E. H. Ohlstein, and R. N. Willette
In Vivo Activation of Peroxisome Proliferator-Activated Receptor-{delta} Protects the Heart from Ischemia/Reperfusion Injury in Zucker Fatty Rats
J. Pharmacol. Exp. Ther., May 1, 2008; 325(2): 466 - 474.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. B. Pillai, M. Chen, S. B. Rajamohan, S. Samant, V. B. Pillai, M. Gupta, and M. P. Gupta
Activation of SIRT1, a class III histone deacetylase, contributes to fructose feeding-mediated induction of the {alpha}-myosin heavy chain expression
Am J Physiol Heart Circ Physiol, March 1, 2008; 294(3): H1388 - H1397.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
P. V. G. Katakam, J. E. Jordan, J. A. Snipes, C. D. Tulbert, A. W. Miller, and D. W. Busija
Myocardial preconditioning against ischemia-reperfusion injury is abolished in Zucker obese rats with insulin resistance
Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2007; 292(2): R920 - R926.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
M. Joyeux-Faure, E. Rossini, C. Ribuot, and P. Faure
Fructose-fed rat hearts are protected against ischemia-reperfusion injury.
Experimental Biology and Medicine, April 1, 2006; 231(4): 456 - 462.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. K. Jagadeesha, T. E. Lindley, J. DeLeon, R. V. Sharma, F. Miller, and R. C. Bhalla
Tempol therapy attenuates medial smooth muscle cell apoptosis and neointima formation after balloon catheter injury in carotid artery of diabetic rats
Am J Physiol Heart Circ Physiol, September 1, 2005; 289(3): H1047 - H1053.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
W. Zhou, X.-L. Wang, T. L. Kaduce, A. A. Spector, and H.-C. Lee
Impaired arachidonic acid-mediated dilation of small mesenteric arteries in Zucker diabetic fatty rats
Am J Physiol Heart Circ Physiol, May 1, 2005; 288(5): H2210 - H2218.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
P. V. G. Katakam, C. D. Tulbert, J. A. Snipes, B. Erdos, A. W. Miller, and D. W. Busija
Impaired insulin-induced vasodilation in small coronary arteries of Zucker obese rats is mediated by reactive oxygen species
Am J Physiol Heart Circ Physiol, February 1, 2005; 288(2): H854 - H860.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2003 by the American Society for Pharmacology and Experimental Therapeutics.